Global Markets for Chiral Technology -- Focus on Europe

Report Code: BIO102A

Publish Date: Apr 2012

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2685

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global chiral technology market reached nearly $4.9 billion in 2010 and $5.2 billion in 2011. The market is expected to reach $7.1 billion by 2016, a compound annual growth rate (CAGR) of 6.5%.
  • The European market for chiral technologies reached $2.0 billion in 2010 and nearly $2.2 billion in 2011. The market is expected to reach $2.8 billion by 2016, a CAGR of 5.1%.
  • The European market for chiral synthesis reached $1.7 billion in 2010 and $1.8 billion in 2011. The market is expected to reach $2.3 billion by 2016, a CAGR of 4.8%.

INTRODUCTION

STUDY OBJECTIVES

BCC’s goal in conducting this study is to provide an overview of the current and future global market for chiral products and technologies used in today’s world.  The key objective is to present a comprehensive analysis of the current market and its future direction in the chiral market as an important tool in various therapeutic industries and other industries.

This report explores present and future strategies within the chiral market, including the synthesis, separation and analysis of chiral products.  The improvisation of the market, the setbacks and the needs of the market are discussed in this report.  An overview of chirality, and the chiral products and technologies used in the past and currently are discussed in this report.

A detailed analysis of the structure of the chiral industry has been conducted.  This includes chiral synthesis, chiral separation/resolution and chiral analysis.  Revenues are broken down by global region from 2009 to 2011 and estimated for the five-year period from 2011 through 2016.

Applications for chiral products and technologies are also discussed in this report, with an emphasis on the usage in the pharmaceutical, biochemical and agrochemical industries.  The report also covers significant patents and their allotment in each category.

REASONS FOR DOING THIS STUDY

This study was conducted to provide an update of new developments in the chiral technology market.  The current study covers the global market for chiral products, with a specific focus on the U.S. markets, European markets and emerging markets.  This study was conducted to provide a detailed market analysis of chiral-enabling products, including the factors influencing this market.  New advancements and the need for enantiopure compounds have driven growth within this market.  This study looks at most of the systems influenced by these factors.

Acquisition strategies and collaborations by companies are also covered in this report.  This study also discusses the strength and weaknesses of each system/technology in light of the new technologies, growing competition and changing customer needs.

INTENDED AUDIENCE

This study contributes to the areas of market growth in therapeutic segments through chiral products and technologies from the point of view of manufacturers and users.  The pharmaceutical and biopharmaceutical industries, agrochemical industries, physicians, hospitals and research institutes will find this study to be of interest.

SCOPE OF THE STUDY

The scope of this study encompasses the chiral markets with their usage in the pharmaceutical, biotechnical and agrochemical markets.  BCC analyzes each market and its applications by its need for chiral products, their regulatory environment, technology involved, market projections and market share.  Technological issues include the latest trends and developments.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study.  BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources.  Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical and biotechnical experts.  Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study.  Included were manufacturers and end users of chiral products.  Data were gathered from various industry sources.  BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts.  Exhaustive investigations of databases by key terminology were completed.  In addition, data were compiled from current financial, trade and government sources.

BCC ONLINE SERVICES

BCC offers an online information retrieval service.  BCC’s home page, located at www.bccresearch.com, enables readers to:

  • Examine its complete catalog of technology market research reports, tables of content and order directly from BCC Research.
  • Subscribe to any of its more than 20 monthly technology/marketing newsletters.
  • Read announcements of upcoming reports and newly launched newsletters.
  • Register for BCC’s well-known conferences.
  • Request additional information about any BCC product.
  • Take advantage of special offers.

DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature.  This information does not constitute managerial, legal or accounting advice; nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature.  The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Chiral Technology -- Focus on Europe295Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY3Free
Chapter- 3: OVERVIEW7Free
Chapter- 4: CHIRAL TECHNOLOGY22Free
Chapter- 5: REGULATORY ASPECTS9Free
Chapter- 6: MARKET LEADERS IN CHIRAL PRODUCTS19Free
Chapter- 7: NEW DEVELOPMENTS13Free
Chapter- 8: GLOBAL MARKET ANALYSIS53Free
Chapter- 9: EUROPEAN MARKET ANALYSIS57Free
Chapter- 10: MARKET BY INDUSTRY APPLICATION27Free
Chapter- 11: PATENT ANALYSIS15Free
Chapter- 12: CURRENT CHIRAL MARKET ENVIRONMENT7Free
Chapter- 13: C. CRAMER & CO. GMBH56Free
Chapter- 14: APPENDIX: ABBREVIATIONS3Free

Related Reports

Metamaterials: Technologies and Global Markets

Published - Jan 2012 | Publisher - Andrew McWilliams | Code - AVM067B

BCC estimates the global market for metamaterials was worth $222.3 million in 2010 and $256.1 million in 2011.  BCC expects the market to grow to $758.7 million by 2016, a compound annual growth rate (CAGR) of 24.3% since 2011, and to reach nearly $1.9 billion by 2021, a CAGR of 19.6% between 2016 and 2021.

Liver Disease Treatments: The Global Market

Published - Jan 2012 | Publisher - Shalini Shahani Dewan | Code - PHM057B

In 2009, the global market for drugs used to treat liver disease was worth approximately $12.4 billion. Sales in 2010 decreased and the market did not see much progress, causing overall global sales to remain stagnant at $12.4 billion. Estimated sales in 2011 a projected $12 billion (excluding protease inhibitors).  The market is expected to rise at a CAGR of 3.3% and reach nearly $14.2 billion by 2016.

Advanced Drug Delivery Systems: Technologies and Global Markets

Published - Oct 2011 | Publisher - Shalini Shahani Dewan | Code - PHM006H

The global market for drug delivery systems in 2010 was $131.6 billion and is expected to increase to $137.8 billion by the end of 2011. The market is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016.

Antiseptics and Disinfectants

Published - Jul 2011 | Publisher - Shalini Shahani Dewan | Code - CHM052B

The global market for antiseptics and disinfectants in 2009 was at about $3.4 billion, and with a 12% increase, sales reached about $3.8 billion in 2010. The market is expected to rise at a compound annual growth rate (CAGR) of 11.1% and reach $7.1 billion by 2016.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Chiral Technology -- Focus on Europe
Customize Report